[A new antidiabetic agent: glyclazide. A study of glycemic regulation].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D003517:Cyclopentanes / Q000008:administration & dosage / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005943:Gluconeogenesis / Q000187:drug effects; D006019:Glycolysis / Q000187:drug effects; D006029:Glycosuria; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009765:Obesity; D011758:Pyrroles / Q000008:administration & dosage / Q000627:therapeutic use; D013223:Statistics as Topic; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D011758:Pyrroles; D013453:Sulfonylurea Compounds
Un nouvel antidiabétique: le gliclazide. Etude de la régulation glycémique.